SCHEMBL468355

SCHEMBL468355

CC(=O)C(=O)Oc1ccccc1.[NaH]

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.50
MAPT P10636 4/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 2/20 0.46
HSP90AA1 P07900 1/20 0.46
TDP1 Q9NUW8 3/20 0.45
ATM Q13315 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
CYP1A2 P05177 1/20 0.42
KDM4E B2RXH2 1/20 0.41
NSD2 O96028 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7381150 0.98 ELANE (0.49) ELANEMAPTALDH1A1GAAHSP90AA1
SCHEMBL43236 0.98 ELANE (0.52) ELANEMAPTALDH1A1GAAHSP90AA1
Ammonia Solution, Strong SCHEMBL9215530 0.95 ELANE (0.50) ELANEMAPTALDH1A1GAAHSP90AA1
SCHEMBL28233230 0.95 ELANE (0.50) ELANEMAPTALDH1A1GAAHSP90AA1
SCHEMBL3408863 0.95 ELANE (0.50) ELANEMAPTALDH1A1GAAHSP90AA1
SCHEMBL9217788 0.95 ELANE (0.50) ELANEMAPTALDH1A1GAAHSP90AA1
SCHEMBL9217983 0.95 ELANE (0.50) ELANEMAPTALDH1A1GAAHSP90AA1
SCHEMBL28232348 0.95 ELANE (0.50) ELANEMAPTALDH1A1GAAHSP90AA1
SCHEMBL9218275 0.95 ELANE (0.50) ELANEMAPTALDH1A1GAAHSP90AA1
Benzoic Acid SCHEMBL8506924 0.88 DAO (0.54) ELANEMAPTALDH1A1GAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11162124-B2 Alcohol dehydrogenase mutant and application thereof in cofactor regeneration JIANGNAN UNIVERSITY (CN) 2021-11-02 US claimed
US-20200362375-A1 Alcohol Dehydrogenase Mutant and Application thereof in Cofactor Regeneration JIANGNAN UNIVERSITY (CN) 2020-11-19 US claimed
CN-107033089-B A kind of preparation method of α-Ketophenylalanine Calcium 浙江昂利泰制药有限公司 2019-06-21 CN claimed
CN-106366114-A 2-Oxo-3-phenylpropionic acid p-methylbenzoyl hydrazone dibenzyltin complex, and preparation method and application thereof 衡阳师范学院 2017-02-01 CN claimed
CN-106279261-A A kind of 2 carbonyl 3 phenylpropionic acids are to toluyl hydrazone di-n-butyl tin coordination compound and its preparation method and application 衡阳师范学院 2017-01-04 CN claimed
WO-2009018368-A1 COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2009-02-05 WO claimed
US-5360927-A EFFICIENCY DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) 1994-11-01 US claimed
EP-0422162-A4 PROCESS FOR PREPARING SODIUM PHENYLPYRUVATE FROM CALCIUM PHENYLPYRUVATE 1991-09-25 EP claimed
EP-0422162-A1 PROCESS FOR PREPARING SODIUM PHENYLPYRUVATE FROM CALCIUM PHENYLPYRUVATE THE NUTRASWEET COMPANY (US) 1991-04-17 EP claimed
WO-1990011993-A1 PROCESS FOR PREPARING SODIUM PHENYLPYRUVATE FROM CALCIUM PHENYLPYRUVATE THE NUTRASWEET COMPANY (US) 1990-10-18 WO claimed
US-4912255-A Process for preparing sodium phenylpyruvate from calcium phenylpyruvate NUTRASWEET COMPANY, THE 1990-03-27 US claimed
US-4518800-A ONE STEP, FROM BENZALDEHYDE AND HYDANTOIN USING ETHANOLAMINE CATALYST, TREATING WITH SODIUM HYDROXIDE THEN HYDROCHLORIC ACID SOCIETE FRANCAISE HOECHST (FR) 1985-05-21 US claimed
JP-54119429-A None JP disclosed
US-20260123658-A1 Methods of Increasing the Beneficial Properties of Fermented Foods The Brd. of Trustees of the Univ. of Illinois (US) 2026-05-07 US disclosed
US-20250369029-A1 METHOD FOR PRODUCING AMINO ACID AND PEPTIDE COMPOUND, USING ENZYME AND ADDITIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2025-12-04 US disclosed
CN-115975965-B Lactate dehydrogenase and encoding gene, recombinant vector, recombinant thallus and starter thereof, and applications of lactate dehydrogenase and starter 台州学院 2025-07-08 CN disclosed
EP-0050866-A1 Antihypertensive 1-substituted cyclic lactam-2-carboxylic acids E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-05-05 EP disclosed
US-4326031-A REDUCTION DEGUSSA AG (DE) 1982-04-20 US disclosed
US-4296110-A Antihypertensive I-substituted cyclic lactam-2-carboxylic acids E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-10-20 US disclosed
JP-S54119429-A NOVEL PREPARATION OF OPTICALLY ACTIVE ALPHA AMINO ACID RIKAGAKU KENKYUSHO 1979-09-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260123658-A1 Methods of Increasing the Beneficial Properties of Fermented Foods AADAT, IDO1, ALDOA ELANE 4077/4885MAPT 1131/4885ALDH1A1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.